Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Cyrill Brunner"'
Leveraging molecular structure and bioactivity with chemical language models for de novo drug design
Autor:
Michael Moret, Irene Pachon Angona, Leandro Cotos, Shen Yan, Kenneth Atz, Cyrill Brunner, Martin Baumgartner, Francesca Grisoni, Gisbert Schneider
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-12 (2023)
Generative Deep Learning holds promise for mining the unexplored “chemical universe” for new drugs. Here, the authors demonstrate the de novo design of phosphoinositide 3-kinase gamma (PI3Kγ) inhibitors for the PI3K/Akt pathway in human tumor ce
Externí odkaz:
https://doaj.org/article/813fd08e95d44abfaa961a2900ee404a
Autor:
Joanna Hajduk, Cyrill Brunner, Sebastian Malik, Jana Bangerter, Gisbert Schneider, Marco Thomann, Dietmar Reusch, Renato Zenobi
Publikováno v:
mAbs, Vol 12, Iss 1 (2020)
Minor changes in the quality of biologically manufactured monoclonal antibodies (mAbs) can affect their bioactivity and efficacy. One of the most important variations concerns the N-glycosylation pattern, which directly affects an anti-tumor mechanis
Externí odkaz:
https://doaj.org/article/00b95ffc1ec447b89c8cad52e5a4528a
Publikováno v:
Toxicon. 175:36-43
A dual-receptor interaction with a polysialoganglioside and synaptic vesicle glycoprotein 2 (SV2) is required for botulinum neurotoxin A (BoNT) toxicity. Here, we review what is currently known about the BoNT/A-SV2 interaction based on structural stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84e0f675fe5500339b0d4af2622e04b5
https://doi.org/10.1016/j.toxicon.2019.11.010
https://doi.org/10.1016/j.toxicon.2019.11.010
Autor:
Karthiga Santhana Kumar, Cyrill Brunner, Matthias Schuster, Levi Kopp, Alexandre Gries, Shen Yan, Simon Jurt, Kerstin Moehle, Dominique Bruns, Michael Grotzer, Oliver Zerbe, Gisbert Schneider, Martin Baumgartner
Rational targeting of proteins involved in controlling cancer cell behavior with small bioactive compounds can accelerate anti-cancer drug discovery. We report the identification of a new small molecule compound inhibitor of the FGFR adaptor protein
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7b6f9b1a4ae630302c971a13d441da91
https://doi.org/10.21203/rs.3.rs-1359115/v1
https://doi.org/10.21203/rs.3.rs-1359115/v1
Generative chemical language models (CLMs) can be used for de novo molecular structure generation. These CLMs learn from the structural information of known molecules to generate new ones. In this paper, we show that “hybrid” CLMs can additionall
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::817706cc80d3090e5b2f7c691f914407
https://doi.org/10.33774/chemrxiv-2021-xzgst
https://doi.org/10.33774/chemrxiv-2021-xzgst
Autor:
Cyrill Brunner, Agnieszka M Olechwier, Na Wu, Christopher G. Tate, Pikyee Ma, Patricia C. Edwards, Xavier Deupi, Renato Zenobi, Ching-Ju Tsai, Gebhard F. X. Schertler, Gisbert Schneider
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America
Significance G protein–coupled receptors (GPCRs) are important pharmaceutical targets for the treatment of a broad spectrum of diseases. Upon ligand binding, GPCRs initiate intracellular signaling pathways by interacting with partner proteins. Assa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0dfdcacae417e2dbaf83e0a6d734ad3c
http://europepmc.org/articles/PMC8346855
http://europepmc.org/articles/PMC8346855
Publikováno v:
Angewandte Chemie. 131:7212-7216
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::071ad11c4b9a3cc7c82d3a4d8e8aeda7
https://doi.org/10.1002/ange.201902022
https://doi.org/10.1002/ange.201902022
Publikováno v:
Analytical Chemistry, 93 (39)
Fast and efficient handling of ligands and biological targets are required in bioaffinity screening based on native electrospray ionization mass spectrometry (ESI-MS). We use a prototype microfluidic autosampler, called the “gap sampler”, to sequ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78c5da33883b87fc0495c220ecc1c79f
Autor:
Gisbert Schneider, Jana Bangerter, Renato Zenobi, Joanna Hajduk, Marco Thomann, Cyrill Brunner, Sebastian Malik, Dietmar Reusch
Publikováno v:
mAbs
mAbs, 12 (1)
mAbs, 12 (1)
Minor changes in the quality of biologically manufactured monoclonal antibodies (mAbs) can affect their bioactivity and efficacy. One of the most important variations concerns the N-glycosylation pattern, which directly affects an anti-tumor mechanis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e33b590ea90274453b372e95b436e2aa
http://europepmc.org/articles/PMC7153833
http://europepmc.org/articles/PMC7153833
Autor:
Michael A. Grotzer, Oliver Zerbe, Gisbert Schneider, Cyrill Brunner, Martin Baumgartner, Matthias Schuster, Karthiga Santhana Kumar
Publikováno v:
Neuro-Oncology
FGF2, the ligand of FGF receptors (FGFRs), is expressed in the developing and adult brain. FGF2-FGFR1 signaling causes the induction and maintenance of cancer stem cells through ERK-dependent up-regulation of ZEB1 and Olig2 in glioblastoma. In SHH me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3ffce87fcb94287aa832ff935019026
https://doi.org/10.1093/neuonc/noaa222.588
https://doi.org/10.1093/neuonc/noaa222.588